BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 28019667)

  • 21. Side population cells as prototype of chemoresistant, tumor-initiating cells.
    Richard V; Nair MG; Santhosh Kumar TR; Pillai MR
    Biomed Res Int; 2013; 2013():517237. PubMed ID: 24294611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
    Topcul M; Cetin I
    J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of side population cells isolated from the colon cancer cell line SW480.
    Xiong B; Ma L; Hu X; Zhang C; Cheng Y
    Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cells in osteosarcoma.
    Brown HK; Tellez-Gabriel M; Heymann D
    Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
    Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor initiating cells.
    Bansal N; Banerjee D
    Curr Pharm Biotechnol; 2009 Feb; 10(2):192-6. PubMed ID: 19199951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
    Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
    Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
    Oh J; Hlatky L; Jeong YS; Kim D
    Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An update: stem cell and cancer stem cells].
    Liu YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
    [No Abstract]   [Full Text] [Related]  

  • 37. Research progress and prospects of markers for liver cancer stem cells.
    Zhu CP; Wang AQ; Zhang HH; Wan XS; Yang XB; Chen SG; Zhao HT
    World J Gastroenterol; 2015 Nov; 21(42):12190-6. PubMed ID: 26576103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells.
    Yu S; Zhang R; Liu F; Wang H; Wu J; Wang Y
    Oncol Rep; 2012 Aug; 28(2):561-6. PubMed ID: 22641197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment.
    Islam F; Gopalan V; Smith RA; Lam AK
    Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.